Table 2 MedDRA preferred terms that used to retrieve adverse event cases of IL-6 receptor antagonists in FAERS

LIVER INJURY

LIVER DAMAGE

HEPATIC DAMAGE

HEPATOTOXICITY

HEPATITIS

NONALCOHOLIC FATTY LIVER DISEASE

LIVER FATTY INFILTRATION

CHOLESTASIS

BILIARY CHOLANGITIS

HEPATIC ENCEPHALOPATHY

HEPATIC FAILURE

PORTAL HYPERTENSION

HEPATIC NECROSIS

DILI

HEPATOCELLULAR INJURY

HEPATIC ENZYME ABNORMAL

BLOOD BILIRUBIN ABNORMAL